Simplified, Sensitive, & Scalable JAK2 V617F Mutation Detection
The QuantideX® qPCR JAK2 Kit delivers highly sensitive and quantitative detection of the JAK2 V617F mutation relative to an endogenous control sequence—both measured simultaneously in a streamlined, one-well workflow, with data analysis software included and results in less than 2.5 hours.
End-to-end solution simplifying molecular testing for this critical biomarker used in management of Myeloproliferative Neoplasm conditions (MPNs).
Reduced Complexity
- JAK2 V617F mutation quantitative detection in one reaction.
- Ready-to-use kit with all qPCR reagents, controls, and calibrators included.
- Compatible with commonly used laboratory equipment.
Quality Results
- High sensitivity exceeding ELN/IWG-MPN recommendations and WHO reference panel.
- Sample-specific reaction LODs automatically calculated and reported.
Optimized Workflow
- Multiplex design reduces run setup steps and maximizes plate-well efficiency.
- Harmonized assay design enables combined batching with other QuantideX qPCR HemOnc kits.
- Supports wide range of DNA input and multiple DNA isolation methods.
- Automated data analysis and reporting software included.
| qPCR | Data Analysis | Total | |
|---|---|---|---|
| Hands-On Time | 30 min | 10 min | 40 min |
| Instrument Time | 90 min | 90 min |
Ready to Streamline your JAK2 Workflow?
Download flyer >
* The QuantideX qPCR ESR1 exoMutation Kit is for Research Use Only (RUO) and not for use in diagnostic procedures.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.